Copyright
©The Author(s) 2019.
World J Gastrointest Surg. Dec 27, 2019; 11(12): 422-432
Published online Dec 27, 2019. doi: 10.4240/wjgs.v11.i12.422
Published online Dec 27, 2019. doi: 10.4240/wjgs.v11.i12.422
Table 4 Mortality, length of Intensive care unit stay and ventilator free days in polymyxin B hemoperfusion and control groups
| PMX-HP (n = 20) | Control (n = 20) | P value | |
| ICU mortality (%) | 4 (20) | 8 (40) | 0.168 |
| 28-d mortality (%) | 9 (45) | 8 (40) | 0.749 |
| In hospital mortality (%) | 10 (50) | 10 (50) | 1.000 |
| Length of ICU stay (d) | 10.9 ± 3.9 (5-19) | 14.6 ± 6.4 (5-23) | 0.036 |
| Mechanical ventilator days (d) | 5.1 ± 4.7 (0-16) | 4.9 ± 5.4 (0-18) | 0.926 |
- Citation: Kim JJ, Park YJ, Moon KY, Park JH, Jeong YK, Kim EY. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock. World J Gastrointest Surg 2019; 11(12): 422-432
- URL: https://www.wjgnet.com/1948-9366/full/v11/i12/422.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v11.i12.422